Chengdu Kanghong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 26.9% in First Quarter of 2022

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. (成都康弘药业集团股份有限公司) (002773.SZ) reported a net profit of 296.5 million yuan in the first quarter of 2022, up 26.9% year-on-year.

Meanwhile, the company posted 895.2 million yuan in revenue, down 2.1% year-on-year.

At the end of the reporting period, it had 7.3 billion yuan in total assets and 865.4 million yuan in total liabilities, with a liability-to-asset ratio of 11.9%.